4SC 203
Alternative Names: 4SC-203; SC71710Latest Information Update: 09 Oct 2013
At a glance
- Originator 4SC; ProQinase
- Developer 4SC
- Class Antineoplastics; Inositol phosphates; Small molecules
- Mechanism of Action Fms-like tyrosine kinase 3 inhibitors; Focal adhesion protein tyrosine kinase inhibitors; Vascular endothelial growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute myeloid leukaemia; Solid tumours
Most Recent Events
- 14 May 2013 Discontinued - Phase-I for Acute myeloid leukaemia (in volunteers) in Germany (IV)
- 14 May 2013 Discontinued - Preclinical for Solid tumours in Germany (IV)
- 07 Jan 2011 Preclinical trials in Solid tumours in Germany (IV)